Nuvectis Pharma Inc

NVCT

Company Profile

  • Business description

    Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of innovative precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.

  • Contact

    1 Bridge Plaza
    2nd Floor, Suite 275
    Fort LeeNJ07024
    USA

    T: +1 201 614-3150

    https://www.nuvectis.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2025

    Employees

    13

Stocks News & Analysis

stocks

Are investors missing the boat on this future ASX leader?

The market is underestimating the clear path to profitability.
stocks

ASX shares plunge but remain undervalued

Shares drop 17% after guidance is revised but we still see value.
stocks

Ask the analyst: Why have markets shunned APA Group?

Australia's premier gas infrastructure firm used to be a market darling, but its shares have taken a severe de-rating in recent years.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,470.201.60-0.02%
CAC 407,423.6715.030.20%
DAX 4020,271.33138.480.69%
Dow JONES (US)42,518.28221.160.52%
FTSE 1008,201.5422.65-0.28%
HKSE19,256.7736.990.19%
NASDAQ19,044.3943.71-0.23%
Nikkei 22538,576.66102.360.27%
NZX 50 Index12,946.0061.620.48%
S&P 5005,842.916.690.11%
S&P/ASX 2008,225.905.10-0.06%
SSE Composite Index3,232.967.98-0.25%

Market Movers